Apollo Therapeutics

Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating fundamental medical research into innovative new medicines. They have a unique approach, partnering with six of the world's leading universities and research institutes to gain access to groundbreaking discoveries in biology and basic medical research. This gives them a strong foundation for developing a large, diversified portfolio of novel therapeutics with uncorrelated risk.

The company is headquartered in Cambridge, UK, and has offices in Boston and Chicago, USA. They are backed by leading specialist investors, including Patient Square Capital and Rock Springs Capital, and have raised over $450 million since their inception in 2016. Apollo Therapeutics has a scalable R&D platform and a "hub-and-spoke" model, which allows them to leverage centralized expertise and scale-up capabilities while maintaining a focus on individual asset development. They attract top talent and are committed to advancing promising therapeutics through clinical development and ultimately to patients.

Apollo Therapeutics offers flexible work arrangements for its employees, with no mention of specific policies regarding remote work or flexible hours. However, the company's emphasis on attracting top talent from major pharmaceutical companies suggests a willingness to accommodate individual needs and preferences. The company’s "hub-and-spoke" structure, with separate wholly owned subsidiary companies for each therapeutic program, might also offer flexibility for individuals seeking more autonomy or geographic location flexibility.

Apollo Therapeutics offers a competitive benefits package, including generous equity incentive schemes, to attract and retain top talent. They also pride themselves on a flat, non-hierarchical organization, transparency in decision-making, and a collegiate environment built on excellence without ego.

Apollo Therapeutics is a portfolio biopharmaceutical company committed to translating groundbreaking discoveries in biology and basic medical research into innovative new medicines. They focus on building a large, diversified portfolio of novel therapeutics with uncorrelated risk, aiming to develop first-in-class or best-in-class treatments for serious diseases. Their unique approach involves partnering with six of the world's leading universities and research institutes to access cutting-edge scientific breakthroughs, while leveraging their own expertise in drug discovery and development to efficiently advance these discoveries into clinical trials and ultimately, to patients.

Apollo Therapeutics promotes a collaborative and truth-seeking culture that values transparency, open communication, and excellence without ego. They have a flat, non-hierarchical organizational structure, encouraging all employees to contribute their expertise and challenge conventional thinking. The company prioritizes lifelong learning, humility, and continuous improvement, fostering an environment where diverse perspectives are welcomed and valued.

Apollo Therapeutics champions a diverse, equitable, and inclusive work environment, fostering a culture of respect and collaboration. They seek to recruit and retain a wide range of talent, valuing individual contributions and perspectives regardless of background, ethnicity, gender, sexual orientation, or any other protected characteristic. The company believes in creating a space where everyone feels valued, respected, and empowered to contribute their best to the shared mission of developing breakthrough medicines.